All In Biotech

Drug Trial Radar · NCT02230696

Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic Rhinitis

Last checked: Nov 19, 2026Latest source record: Oct 22, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 951 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

951

Actual

Start

Aug 2014

Primary completion

Feb 2015

Study completion Feb 2015

Sponsor

Lead sponsor
Padagis LLCIndustry
Sponsor type
Industry
First posted
Sep 3, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 12 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To compare safety and efficacy of Perrigo's steroid drug product compared with an FDA approved steroid drug product in the treatment of subjects with seasonal allergic rhinitis.

Conditions

  • Seasonal Allergic Rhinitis

Interventions

  • Azelastine Hydrochloride/Fluticasone Propionate Nasal SprayDrug

    137 micro-grams Azelastine Hydrochloride, 50 micro-grams Fluticasone Propionate

  • Azelastine Hydrochloride/Fluticasone Propionate Nasal SprayDrug

    137 micro-grams Azelastine Hydrochloride, 50 micro-grams Fluticasone Propionate

  • Placebo nasal sprayDrug

    Placebo nasal spray

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change From Baseline for Mean Reflective Total Nasal Symptom Score (rTNSS)Time frame: Day 1 through Day 14

Locations

30 sites in 1 country. Site status is shown where the registry gives one.

  • Atlanta Allergy & Asthma Clinic, PA

    Stockbridge, Georgia

  • Clinical Research Atlanta (CRA)

    Stockbridge, Georgia

  • Family Allergy and Asthma Research Institute

    Louisville, Kentucky

  • Chesapeake Clinical Research, Inc.

    Baltimore, Maryland

  • NEMRA Northeast Medical Research Associates, Inc

    North Dartmouth, Massachusetts

  • Clinical Research Institute, Inc.

    Minneapolis, Minnesota

  • Clinical Research Institute LLC

    Minneapolis, Minnesota

  • Clinical Research of the Ozarks, Inc.

    Columbia, Missouri

  • Clinical Research of the Ozarks, Inc.

    Rolla, Missouri

  • The Clinical Research Center, LLC

    St Louis, Missouri

  • Princeton Center for Clinical Research

    Skillman, New Jersey

  • Island Medical Research, P.C.

    Rockville Centre, New York

  • Allergy and Asthma Center of NC

    High Point, North Carolina

  • North Carolina Clinical Research

    Raleigh, North Carolina

  • Toledo Center for Clinical Research

    Sylvania, Ohio

  • Allergy, Asthma & Clinical Research Center

    Oklahoma City, Oklahoma

  • Vital Prospects Clinical Research Institute, P.C.

    Tulsa, Oklahoma

  • National Allergy, Asthma & Urticaria Centers of Charleston

    North Charleston, South Carolina

  • New Phase Research and Development

    Knoxville, Tennessee

  • ISIS Clinical Research, LLC

    Austin, Texas

  • Sirius Clinical Research LLC

    Austin, Texas

  • AARA Research Center

    Dallas, Texas

  • Pharmaceutical Research & Consulting Inc.

    Dallas, Texas

  • Western Sky Medical Research

    El Paso, Texas

  • Central Texas Health Research

    New Braunfels, Texas

  • Quality Research Inc.

    San Antonio, Texas

  • Diagnostics Research Group

    San Antonio, Texas

  • Sylvana Research Associates

    San Antonio, Texas

  • Allergy Asthma Research Institute

    Waco, Texas

  • The Asthma & Allergy Center - Bellevue

    Bellevue, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.